Herceptin and Ototoxicity - a phase IV clinical study of FDA data
Ototoxicity is found among people who take Herceptin, especially for people who are female, 40-49 old.
The phase IV clinical study analyzes which people take Herceptin and have Ototoxicity. It is created by eHealthMe based on reports of 35,542 people who have side effects when taking Herceptin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
35,542 people reported to have side effects when taking Herceptin.
Among them, 7 people (0.02%) have Ototoxicity.
What is Herceptin?
Herceptin has active ingredients of trastuzumab. It is often used in breast cancer. eHealthMe is studying from 35,871 Herceptin users for its effectiveness, alternative drugs and more.
What is Ototoxicity?
Ototoxicity (damage to the ear) is found to be associated with 595 drugs and 333 conditions by eHealthMe.
Number of Herceptin and Ototoxicity reports submitted per year:
Gender of people who have Ototoxicity when taking Herceptin *:
- female: 100 %
- male: 0.0 %
Age of people who have Ototoxicity when taking Herceptin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 50.0 %
- 50-59: 16.67 %
- 60+: 0.0 %
Common drugs people take besides Herceptin *:
- Taxotere: 5 people, 71.43%
- Mycostatin: 5 people, 71.43%
- Cisplatin: 5 people, 71.43%
- Kytril: 2 people, 28.57%
- Taxol: 1 person, 14.29%
Common side effects people have besides Ototoxicity *:
- Nephropathy Toxic (damage to kidney due to toxins): 4 people, 57.14%
- Tinnitus (a ringing in the ears): 2 people, 28.57%
- Nausea (feeling of having an urge to vomit): 2 people, 28.57%
- Fatigue (feeling of tiredness): 2 people, 28.57%
- Blood Creatinine Increased: 2 people, 28.57%
- Tumor Marker Increased: 1 person, 14.29%
- Rashes (redness): 1 person, 14.29%
- Diarrhea: 1 person, 14.29%
- Blood Calcium Decreased: 1 person, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Herceptin and have Ototoxicity?Check whether Ototoxicity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
Alternative drugs to, pros and cons of Herceptin:
- Herceptin (35,871 reports)
Ototoxicity treatments and more:
- Ototoxicity (1,631 reports)
COVID vaccines that are related to Ototoxicity:
- Ototoxicity in Moderna COVID Vaccine
- Ototoxicity in Pfizer BioNTech Covid Vaccine
- Ototoxicity in Johnson and Johnson Covid Vaccine
How severe was Ototoxicity and when was it recovered:
Expand to all the drugs that have ingredients of trastuzumab:
Common drugs associated with Ototoxicity:
All the drugs that are associated with Ototoxicity:
- Ototoxicity (595 drugs)
All the conditions that are associated with Ototoxicity:
- Ototoxicity (333 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on trastuzumab (the active ingredients of Herceptin) and Herceptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clopra and Vancomycin drug interaction - 3 seconds ago
- Fluconazole and Ovarian Cancer - 12 seconds ago
- Levaquin and Deformity - 33 seconds ago
- Midazolam Hydrochloride and Clopra drug interaction - 34 seconds ago
- Lamivudine and Facial Pain - 34 seconds ago